These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents. Gelfand EW; Morris SA; Resch K J Immunol; 1975 Mar; 114(3):919-24. PubMed ID: 1112985 [TBL] [Abstract][Full Text] [Related]
7. Complement-dependent, polymorphonuclear neutrophil-mediated cytotoxicity of herpesvirus-infected cells: possible mechanism(s) of cytotoxicity. Grewal AS; Babiuk LA Immunology; 1980 Jun; 40(2):151-61. PubMed ID: 6157640 [TBL] [Abstract][Full Text] [Related]
8. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes. Ikenami M; Mizuno D; Yamazaki M Jpn J Cancer Res; 1985 Jul; 76(7):637-43. PubMed ID: 3928561 [TBL] [Abstract][Full Text] [Related]
9. Defective natural killer cytotoxicity and polymorphonuclear leukocyte antibody-dependent cellular cytotoxicity in patients with LFA-1/OKM-1 deficiency. Kohl S; Springer TA; Schmalstieg FC; Loo LS; Anderson DC J Immunol; 1984 Dec; 133(6):2972-8. PubMed ID: 6092461 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor. Mandell BF; Spilberg I; Lichtman J J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690 [TBL] [Abstract][Full Text] [Related]
11. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity. Cordier G; Samarut C; Revillard JP Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils. Shau HY; Golub SH J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346 [TBL] [Abstract][Full Text] [Related]
13. The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. Graziano RF; Erbe DV; Fanger MW J Immunol; 1989 Dec; 143(12):3894-900. PubMed ID: 2574205 [TBL] [Abstract][Full Text] [Related]
15. Polymorphonuclear leukocyte tumor cell cytotoxicity: a new method of quantitation. Pardridge DH; Eilber FR; Morton DL Surg Forum; 1977; 28():149-50. PubMed ID: 617401 [No Abstract] [Full Text] [Related]
16. Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils. Dallegri F; Frumento G; Ballestrero A; Goretti R; Patrone F Clin Exp Immunol; 1987 Nov; 70(2):479-83. PubMed ID: 2827922 [TBL] [Abstract][Full Text] [Related]
17. The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity. Clark RA; Szot S J Immunol; 1981 Apr; 126(4):1295-301. PubMed ID: 6259257 [No Abstract] [Full Text] [Related]
18. Inhibition of polymorphonuclear leukocyte-mediated cytotoxicity by hydrocortisone "in vitro". Capsoni F; Meroni PL; Zocchi MR; Plebani A Boll Ist Sieroter Milan; 1981 May; 60(2):113-20. PubMed ID: 7306390 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. Katz P; Simone CB; Henkart PA; Fauci AS J Clin Invest; 1980 Jan; 65(1):55-63. PubMed ID: 6243141 [TBL] [Abstract][Full Text] [Related]
20. Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears. Dallegri F; Frumento G; Minervini F; Muttini P; Patrone F Exp Hematol; 1982 Nov; 10(10):859-66. PubMed ID: 6295791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]